InMode Research and Development Expenses 2018-2024 | INMD

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

InMode research and development expenses from 2018 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

InMode Research and Development Expenses 2018-2024 | INMD

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

InMode research and development expenses from 2018 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$204.2B
Stryker (SYK)	$146.7B
Boston Scientific (BSX)	$132.6B
EssilorLuxottica (ESLOY)	$112.1B
Medtronic (MDT)	$110.6B
Haleon (HLN)	$43.7B
Lonza Group Ag (LZAGY)	$42.2B
GE HealthCare Technologies (GEHC)	$37.7B
ResMed (RMD)	$35.8B
Terumo (TRUMY)	$29.7B
Koninklijke Philips (PHG)	$24.8B
Zimmer Biomet Holdings (ZBH)	$21.9B
Insulet (PODD)	$18.4B
Baxter (BAX)	$17B
Smith & Nephew SNATS (SNN)	$11.1B
BellRing Brands (BRBR)	$10.2B
Bio-Rad Laboratories (BIO)	$9.3B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$6.3B
TG Therapeutics (TGTX)	$5.5B
Haemonetics (HAE)	$4.3B
Prestige Consumer Healthcare (PBH)	$4.2B
ICU Medical (ICUI)	$4.1B
Perrigo (PRGO)	$3.8B
Envista Holdings (NVST)	$3.7B
Neogen (NEOG)	$3.2B
Agios Pharmaceuticals (AGIO)	$3.2B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.8B
QuidelOrtho (QDEL)	$2.7B